10 Recently, several clinical trials have shown the potential effects of these medications in not only in glycemic control but also in the improvement of cardiovascular outcomes, weight loss, osteoarthritis, 11 metabolic dysfunctionassociated steatohepatitis (MASH), 12 Parkinsons disease, 13 chronic kidney disease (CKD) 14 and obstructive sleep apnea
Novo Nordisk recommends injecting semaglutide once weekly, on the same day each week, with or without meals. Each brand pen uses 32G 4mm needles
They can identify problematic interactions and adjust your regimen proactively rather than reactively managing symptoms after they emerge
For providers exploring GLP-1s and other therapeutic peptides in practice, we built the Peptide Protocol Portal to help with exactly that
For these individuals, avoiding alcohol may be the safest option